Nicholas Investment Partners, LP Horizon Therapeutics Public LTD CO Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $8.7 Million - $15.9 Million	-139,397 Reduced 57.34%	103,724 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1.7 Million - $2.44 Million	28,844 Added 13.46%	243,121 $15 Million
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $2.04 Million - $2.98 Million	-25,648 Reduced 10.69%	214,277 $17.1 Million
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $6.82 Million - $8.66 Million	78,862 Added 48.96%	239,925 $25.2 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.26 Million - $1.54 Million	12,818 Added 8.65%	161,063 $17.4 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $7.32 Million - $8.78 Million	-79,594 Reduced 34.93%	148,245 $16.2 Million
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $3.69 Million - $4.1 Million	-42,792 Reduced 15.81%	227,839 $21.3 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $1.04 Million - $1.38 Million	-14,415 Reduced 5.06%	270,631 $24.9 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $1.39 Million - $1.75 Million	20,690 Added 7.83%	285,046 $20.9 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $11.8 Million - $17 Million	212,977 Added 414.52%	264,356 $20.5 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $3.33 Million - $6.28 Million	-110,285 Reduced 68.22%	51,379 $2.86 Million
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $815,114 - $1.26 Million	-32,775 Reduced 16.86%	161,664 $4.79 Million
Q4 2019 Feb 13, 2020	SELL	$25.43 - $36.67 $4.31 Million - $6.22 Million	-169,678 Reduced 46.6%	194,439 $7.04 Million
Q3 2019 Nov 13, 2019	BUY	$23.0 - $27.97 $3.52 Million - $4.28 Million	152,939 Added 72.42%	364,117 $9.92 Million
Q2 2019 Aug 09, 2019	BUY	$22.81 - $28.48 $4.82 Million - $6.01 Million	211,178 New	211,178 $5.08 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account